Loading...
Loading...
shares reached a new 52-week high of $14.42 following a report that IMGN853 demonstrated notable single agent activity for patients with platinum-resistant ovarian cancer.
Ignyta IncRXDX shares touched a new 52-week high of $12.54 after the company reported Phase 1 clinical trial data for Entrectinib.
Altera Corporation ALTR shares gained 6.14 percent to reach a new 52-week high of $51.85.
Intel CorporationINTC announced its plans to buy Altera for $16.7 billion.
OM Group, Inc. OMG shares jumped 27.54 percent to touch a new 52-week high of $33.85 after the company agreed to be acquired by Apollo Affiliated Funds in partnership with Platform Specialty Products Corporation for $34.00 per share in cash.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in